{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2017:E42CQGYWJJNXOVZIBHRWJ7KLUN","short_pith_number":"pith:E42CQGYW","canonical_record":{"source":{"id":"1705.07099","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2017-05-19T17:23:38Z","cross_cats_sorted":["cs.LG"],"title_canon_sha256":"98c3d62887bcee46d71bddeb575bc1141f03d22f23855cd3e790b0751e6aa6be","abstract_canon_sha256":"a116bd42e2f0affec45502b6737b5c44d316ddb8c478a8de439a62d788fe1f42"},"schema_version":"1.0"},"canonical_sha256":"2734281b164a5b77572809e364fd4ba36337f0bcfa098825abced83ec2386702","source":{"kind":"arxiv","id":"1705.07099","version":2},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1705.07099","created_at":"2026-05-18T00:43:20Z"},{"alias_kind":"arxiv_version","alias_value":"1705.07099v2","created_at":"2026-05-18T00:43:20Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1705.07099","created_at":"2026-05-18T00:43:20Z"},{"alias_kind":"pith_short_12","alias_value":"E42CQGYWJJNX","created_at":"2026-05-18T12:31:12Z"},{"alias_kind":"pith_short_16","alias_value":"E42CQGYWJJNXOVZI","created_at":"2026-05-18T12:31:12Z"},{"alias_kind":"pith_short_8","alias_value":"E42CQGYW","created_at":"2026-05-18T12:31:12Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2017:E42CQGYWJJNXOVZIBHRWJ7KLUN","target":"record","payload":{"canonical_record":{"source":{"id":"1705.07099","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2017-05-19T17:23:38Z","cross_cats_sorted":["cs.LG"],"title_canon_sha256":"98c3d62887bcee46d71bddeb575bc1141f03d22f23855cd3e790b0751e6aa6be","abstract_canon_sha256":"a116bd42e2f0affec45502b6737b5c44d316ddb8c478a8de439a62d788fe1f42"},"schema_version":"1.0"},"canonical_sha256":"2734281b164a5b77572809e364fd4ba36337f0bcfa098825abced83ec2386702","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:43:20.392369Z","signature_b64":"IDaYhKOO52rxKz30iOK9gE0vierbz1cvbM+Ot2zOznt88WMcxzsEd6/2sb2vu72G/kg9OHV6QLODuzhGR+M+Ag==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"2734281b164a5b77572809e364fd4ba36337f0bcfa098825abced83ec2386702","last_reissued_at":"2026-05-18T00:43:20.391868Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:43:20.391868Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1705.07099","source_version":2,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:43:20Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"W18lyWEr+Mf/slgTIly0Og6nCCEqKdp8jld/4l/KANXjwuawlCUD7Px/byeHe8n7eTkAkCOw576G9UFtpEBUCA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-03T18:26:01.435146Z"},"content_sha256":"37be14e3e531d4a71fac8ad8d0bb079d403e44ba386ee61149560f2bd89f8d31","schema_version":"1.0","event_id":"sha256:37be14e3e531d4a71fac8ad8d0bb079d403e44ba386ee61149560f2bd89f8d31"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2017:E42CQGYWJJNXOVZIBHRWJ7KLUN","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Machine learning for classification and quantification of monoclonal antibody preparations for cancer therapy","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["cs.LG"],"primary_cat":"q-bio.QM","authors_text":"Alexandre Gramfort, Ali Tfayli, Arlette Baillet-Guffroy, Bal\\'azs K\\'egl, Camille Marini, David Nguyen, Eric Caudron, Laetitia Le, Mehdi Cherti, Patrice Prognon, Pierre Chaminade, Sana Tfaili","submitted_at":"2017-05-19T17:23:38Z","abstract_excerpt":"Monoclonal antibodies constitute one of the most important strategies to treat patients suffering from cancers such as hematological malignancies and solid tumors. In order to guarantee the quality of those preparations prepared at hospital, quality control has to be developed. The aim of this study was to explore a noninvasive, nondestructive, and rapid analytical method to ensure the quality of the final preparation without causing any delay in the process. We analyzed four mAbs (Inlfiximab, Bevacizumab, Ramucirumab and Rituximab) diluted at therapeutic concentration in chloride sodium 0.9% "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1705.07099","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:43:20Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"1uJkUMClHL8Rwi1wn+kaF4WHq7H/b32WcjsuDOjj8w0zrpc+ijeoovyx7Qltf1qZRhmdfOJqrumUVwlbxWaSCA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-03T18:26:01.435508Z"},"content_sha256":"39c5dc2dcb02e9528659d4acec2fba3999b77f0ebb8d909e00d2c498a4cb16d1","schema_version":"1.0","event_id":"sha256:39c5dc2dcb02e9528659d4acec2fba3999b77f0ebb8d909e00d2c498a4cb16d1"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN/bundle.json","state_url":"https://pith.science/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-03T18:26:01Z","links":{"resolver":"https://pith.science/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN","bundle":"https://pith.science/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN/bundle.json","state":"https://pith.science/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN/state.json","well_known_bundle":"https://pith.science/.well-known/pith/E42CQGYWJJNXOVZIBHRWJ7KLUN/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2017:E42CQGYWJJNXOVZIBHRWJ7KLUN","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"a116bd42e2f0affec45502b6737b5c44d316ddb8c478a8de439a62d788fe1f42","cross_cats_sorted":["cs.LG"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2017-05-19T17:23:38Z","title_canon_sha256":"98c3d62887bcee46d71bddeb575bc1141f03d22f23855cd3e790b0751e6aa6be"},"schema_version":"1.0","source":{"id":"1705.07099","kind":"arxiv","version":2}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1705.07099","created_at":"2026-05-18T00:43:20Z"},{"alias_kind":"arxiv_version","alias_value":"1705.07099v2","created_at":"2026-05-18T00:43:20Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1705.07099","created_at":"2026-05-18T00:43:20Z"},{"alias_kind":"pith_short_12","alias_value":"E42CQGYWJJNX","created_at":"2026-05-18T12:31:12Z"},{"alias_kind":"pith_short_16","alias_value":"E42CQGYWJJNXOVZI","created_at":"2026-05-18T12:31:12Z"},{"alias_kind":"pith_short_8","alias_value":"E42CQGYW","created_at":"2026-05-18T12:31:12Z"}],"graph_snapshots":[{"event_id":"sha256:39c5dc2dcb02e9528659d4acec2fba3999b77f0ebb8d909e00d2c498a4cb16d1","target":"graph","created_at":"2026-05-18T00:43:20Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Monoclonal antibodies constitute one of the most important strategies to treat patients suffering from cancers such as hematological malignancies and solid tumors. In order to guarantee the quality of those preparations prepared at hospital, quality control has to be developed. The aim of this study was to explore a noninvasive, nondestructive, and rapid analytical method to ensure the quality of the final preparation without causing any delay in the process. We analyzed four mAbs (Inlfiximab, Bevacizumab, Ramucirumab and Rituximab) diluted at therapeutic concentration in chloride sodium 0.9% ","authors_text":"Alexandre Gramfort, Ali Tfayli, Arlette Baillet-Guffroy, Bal\\'azs K\\'egl, Camille Marini, David Nguyen, Eric Caudron, Laetitia Le, Mehdi Cherti, Patrice Prognon, Pierre Chaminade, Sana Tfaili","cross_cats":["cs.LG"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2017-05-19T17:23:38Z","title":"Machine learning for classification and quantification of monoclonal antibody preparations for cancer therapy"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1705.07099","kind":"arxiv","version":2},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:37be14e3e531d4a71fac8ad8d0bb079d403e44ba386ee61149560f2bd89f8d31","target":"record","created_at":"2026-05-18T00:43:20Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"a116bd42e2f0affec45502b6737b5c44d316ddb8c478a8de439a62d788fe1f42","cross_cats_sorted":["cs.LG"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2017-05-19T17:23:38Z","title_canon_sha256":"98c3d62887bcee46d71bddeb575bc1141f03d22f23855cd3e790b0751e6aa6be"},"schema_version":"1.0","source":{"id":"1705.07099","kind":"arxiv","version":2}},"canonical_sha256":"2734281b164a5b77572809e364fd4ba36337f0bcfa098825abced83ec2386702","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"2734281b164a5b77572809e364fd4ba36337f0bcfa098825abced83ec2386702","first_computed_at":"2026-05-18T00:43:20.391868Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:43:20.391868Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"IDaYhKOO52rxKz30iOK9gE0vierbz1cvbM+Ot2zOznt88WMcxzsEd6/2sb2vu72G/kg9OHV6QLODuzhGR+M+Ag==","signature_status":"signed_v1","signed_at":"2026-05-18T00:43:20.392369Z","signed_message":"canonical_sha256_bytes"},"source_id":"1705.07099","source_kind":"arxiv","source_version":2}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:37be14e3e531d4a71fac8ad8d0bb079d403e44ba386ee61149560f2bd89f8d31","sha256:39c5dc2dcb02e9528659d4acec2fba3999b77f0ebb8d909e00d2c498a4cb16d1"],"state_sha256":"1523a1c743799560ee5c91efa403c3317b6a795065939d232116993c6d1de7b3"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"AkFTg+I5/N4P67LxibQzSiA4Qw+NOWuH+9j576myBsfBbn6KUJgZFnIiWl1YVzCG45qjiYbOoBoAVMDMdAvfBA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-03T18:26:01.437749Z","bundle_sha256":"ee794f75c06d58041b420ab6a0972ed7be08691460cb2fd8ddb0b269a3f79b32"}}